Incorporating MOUD Treatment into Community Supervision

Held at the APPA 2024 Winter Training Institute, Seattle, Washington

Please complete this anonymous web-based survey prior to after the APPA MOUD training.  At the end of this page, is a link to take you to the training evaluation.  It would be appreciated if you also answered the evaluation questions.  Thank you. 

This project was made possible through an agreement with the Justice Speakers Institute, LLC (JSI), and the American Probation and Parole Association.

The points of view expressed are those of the speakers and do not necessarily represent the official position or policies of the Louisiana Department of Public Safety and Corrections.

This training session is sponsored by Indivior.

 

APPA MOUD Training Post Questionnaire

A questionnaire for those who attended the APPA Medications for Opioid Use Disorder training. It should be completed after the training.

1. Occupation (Please identify your position)(Required)
3. Is an Opioid Use Disorder (OUD) considered a disability under the American with Disabilities Act?(Required)
4. Is OUD a chronic disease?(Required)
5. Is recovery possible after a substance use relapse?(Required)
6. Should addressing OUD be a goal of the Justice System?(Required)
7. Is addtional funding needed to address the OUD impact in the Justice System?(Required)
8. How familiar are you with Medications for Opioid Use Disorder (MOUD)?(Required)
9. How familiar are you with Substance Use Disorder (SUD) screening tools?(Required)
10. Should Criminal Justice Professionals rely on treatment experts for changes in, length of time on, and tapering off, of a MOUD?(Required)
11. Is it appropriate for Criminal Justice Professionals to make participation in a MOUD treatment program a requirement of supervision?(Required)
12. Can Criminal Justice Professionals effectively collaborate with Behavioral Health Professionals as part of a MOUD treatment program?(Required)
13. Rate how well your jurisdiction collaborates with Behavioral Health Professionals as part of wrap-around support services.(Required)
14. Rate how well your jurisdiction provides wrap-around support services as part of MOUD treatment programs.(Required)
15. How familiar are you with naloxone?(Required)
16. Does your jurisdiction provide naloxone as an overdose response.(Required)

Please rate the effectiveness of the below medications in treating OUD among the Justice-Involved individuals.

a. Oral Naltrexone(Required)
b. Injectable Naltrexone(Required)
c. Methadone(Required)
d. Oral Buprenorphine(Required)
e. Injectable Buprenorphine(Required)

APPA MOUD Training Evaluation

Please click HERE to go to the training evaluation page.  Thank you.

MENU

Copyright © 2022  Justice Speakers Institute, LLC.
All rights reserved.
The characteristics of honor, leadership and stewardship are integral to the success of JSI.

Therefore the Partners and all Associates subscribe to a Code of Professional Ethics.

JOIN US ON SOCIAL MEDIA

JUSTICE SPEAKERS INSTITUTE, LLC

P.O. BOX 20
NORTHVILLE, MICHIGAN USA 48167

CONTACT US

TOP